PubMedCrossRef 11 Gullick WJ: c-erbB-4/HER4: friend or foe? J Pa

PubMedCrossRef 11. Gullick WJ: c-erbB-4/HER4: friend or foe? J Pathol 2003, 200:279–281.PubMedCrossRef 12. Xu S, Kitayama J, Yamashita H, Souma D, Nagawa H: Nuclear translocation of HER-4/c-erbB-4 is significantly correlated with prognosis of esophageal squamous cell carcinoma. J Surg Oncol 2008, 97:44–50.PubMedCrossRef 13. Ljuslinder I, Malmer B, Isaksson-Mettävainio

ALK inhibitor M, Oberg A, Henriksson R, Stenling R, Palmqvist R: ErbB 1–4 expression alterations in primary colorectal cancers and their corresponding metastases. Anticancer Res 2009, 29:1489–1494.PubMed 14. Rickman OB, Vohra PK, Sanyal B, Vrana JA, Aubry MC, Wigle DA, Thomas CF Jr: Analysis of ErbB receptors in pulmonary carcinoid tumors. Clin Cancer learn more Res 2009, 15:3315–3324.PubMedCrossRef 15. Gilmour LM, Macleod KG, McCaig A, Gullick WJ, Smyth JF, Langdon SP: Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer. Cancer Res 2001, 61:2169–2176.PubMed 16. Pang XG, Fan H, Ge D: Effect of down-regulating HER4 gene on migration and invasion of esophageal carcinoma cell line Eca-109. Fudan Univ J

Med 2008, 35:521–527. 17. Hollmén M, Määttä JA, Bald L, Sliwkowski MX, Elenius K: Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms. Oncogene 2009, 28:1309–1319.PubMedCrossRef 18. Puerta-Gil P, García-Baquero R, Jia AY, Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sánchez-Carbayo M: miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. Am J Pathol 2012, 180:1808–1815.PubMedCrossRef 19. Starr A, Greif J, Vexler A, Ashkenazy-Voghera M, Gladesh V, Rubin Clomifene C, Kerber G, Marmor S, Lev-Ari S, Inbar M, Yarden Y, Ben-Yosef R: ErbB4 selleck chemicals llc increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer

therapy. Int J Cancer 2006, 119:269–274.PubMedCrossRef 20. Tang CK, Concepcion XZ, Milan M, Gong X, Montgomery E, Lippman ME: Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo. Cancer Res 1999, 59:5315–5322.PubMed 21. Guan P, Yin Z, Li X, Wu W, Zhou B: Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res 2012, 31:54.PubMedCrossRef 22. Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DT, Chen DT, Ying SY: Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 2008, 14:2115–2124.PubMedCrossRef 23. Yadav S, Pandey A, Shukla A, Talwelkar SS, Kumar A, Pant AB, Parmar D: miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2. J Biol Chem 2011, 286:37347–37357.PubMedCrossRef 24. Zeng Y, Cullen BR: Sequence requirements for micro RNA processing and function in human cells. RNA 2003, 9:112–123.PubMedCrossRef 25.

Comments are closed.